Washington, United States — Johnson & Johnson’s (J&J) single-dose COVID-19 shot is expected to be authorized by the European Union on Thursday, the bloc’s fourth vaccine in the fight to end its chapter of the pandemic.
Here’s what you need to know.
How safe and effective is it?
Perhaps the most important figure to be aware of is “zero.”
That’s how many people have died from COVID-19 after receiving the shot in a massive global trial of 40,000 people, compared to seven who got the placebo.
Overall, the vaccine prevented moderate to severe COVID-19 by 66.1 percent 28 days after the shot, but this rose to 85.4 percent when considering only severe disease.
What ma…
Keep on reading: What you need to know about the Johnson & Johnson vaccine